There were 866 press releases posted in the last 24 hours and 358,220 in the last 365 days.

Contact

Please use this form to send email to PR contact of this press release:
Junshi Biosciences Announces Lancet Infectious Diseases Publication of Results from the 2nd Phase 3 Study of VV116 for Treating COVID-19

TO:



FROM:

Please check your email address!

Please, do not fill this field.

Please, do not change this field.

Please, do not fill if your javascript is turned off.

captcha image